Venus Remedies Ltd's Board meeting on 10th November 2025 approved the unaudited financial results for the quarter and half-year ending 30th September 2025, acknowledging issues with its subsidiary Venus Pharma GmbH's negative net worth of INR 132.10 Lakhs.